- Home
- PENN vs BHVN Comparison
PENN vs BHVN Comparison
Compare PENN & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PENN
- BHVN
- Stock Information
- Founded
- PENN 1972
- BHVN 2013
- Country
- PENN United States
- BHVN United States
- Employees
- PENN N/A
- BHVN N/A
- Industry
- PENN Hotels/Resorts
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- PENN Consumer Discretionary
- BHVN Health Care
- Exchange
- PENN Nasdaq
- BHVN Nasdaq
- Market Cap
- PENN 3.0B
- BHVN 3.6B
- IPO Year
- PENN 1994
- BHVN 2017
- Fundamental
- Price
- PENN $20.65
- BHVN $35.57
- Analyst Decision
- PENN Buy
- BHVN Strong Buy
- Analyst Count
- PENN 20
- BHVN 13
- Target Price
- PENN $23.38
- BHVN $63.00
- AVG Volume (30 Days)
- PENN 4.6M
- BHVN 1.2M
- Earning Date
- PENN 02-13-2025
- BHVN 02-27-2025
- Dividend Yield
- PENN N/A
- BHVN N/A
- EPS Growth
- PENN N/A
- BHVN N/A
- EPS
- PENN N/A
- BHVN N/A
- Revenue
- PENN $6,304,500,000.00
- BHVN N/A
- Revenue This Year
- PENN $5.90
- BHVN N/A
- Revenue Next Year
- PENN $5.54
- BHVN $197.13
- P/E Ratio
- PENN N/A
- BHVN N/A
- Revenue Growth
- PENN N/A
- BHVN N/A
- 52 Week Low
- PENN $13.50
- BHVN $26.80
- 52 Week High
- PENN $24.57
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- PENN 57.70
- BHVN 37.47
- Support Level
- PENN $17.41
- BHVN $34.20
- Resistance Level
- PENN $20.19
- BHVN $40.46
- Average True Range (ATR)
- PENN 1.03
- BHVN 2.10
- MACD
- PENN 0.19
- BHVN 0.30
- Stochastic Oscillator
- PENN 90.25
- BHVN 21.90
About PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 89% of total sales in 2023; 11% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.